Selank 10 mg

Selank Australia Research and Mechanism

Selank australia is a synthetic heptapeptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro) and analogue of the endogenous immunomodulatory peptide tuftsin. According to research published in PMC, selank was developed at the Institute of Molecular Genetics, Russian Academy of Sciences, in cooperation with the V.V. Zakusov Research Institute of Pharmacology.citeweb_search:24#0 It has pronounced anxiolytic activity and acts as a stable neuropsychotropic, antidepressant, and antistress compound that relieves aggression and fear reaction in different animal species. Selank also demonstrates nootropic action, positively influencing memory and learning processes, and marked immunomodulatory activity.citeweb_search:24#0

Further research in PMC demonstrated that selank enhances the effect of diazepam in reducing anxiety in unpredictable chronic mild stress conditions in rats, with the combination of selank and diazepam almost completely eliminating stress-induced anxiety effects.citeweb_search:24#1 The study confirmed that allosteric modulation of the GABAergic system is one of the molecular mechanisms of selank action.citeweb_search:24#1 It is critical to emphasise that selank is not approved by the TGA for human use in Australia. It is sold strictly for in vitro and laboratory research use only.

Selank Australia Regulatory Status

Selank australia is not listed on the Australian Register of Therapeutic Goods (ARTG) and has no TGA approval for importation, sale, or supply as a therapeutic product. According to ChemicalBook, selank was approved in Russia in 2009 for generalized anxiety disorder and made over-the-counter in 2017.citeweb_search:24#2 However, this regulatory status does not extend to Australia, the United States, or other Western jurisdictions. The FDA has raised concerns about compounded selank products, citing risks of immunogenicity and lack of safety information.citeweb_search:24#12 Pure Peptide Factory supplies selank as a research reference material for analytical, assay development, and comparative neurobiology studies only.

Selank Dosage and Reconstitution

Selank Dosage for Research Protocols

For laboratory research, selank is typically supplied as a 10mg lyophilised powder. According to research protocol references, typical laboratory dosing ranges from 0.3 to 1.0 mg per kg in preclinical models, with administration via intraperitoneal or intranasal routes depending on the research context.citeweb_search:24#2 For in vitro applications, working concentrations of 10 to 100 micromolar are common reference points for studying GABAergic modulation, neurotransmitter pathways, and gene expression changes. Clinical studies in Russia have used 0.15 to 0.3 mg intranasally per day. Gently swirl the vial until fully dissolved. Do not shake vigorously. Allow the solution to settle at room temperature before aliquoting.

Reconstitution Guide

Remove the vial from freezer storage and allow it to equilibrate to room temperature for 15 to 20 minutes. Draw 1.0 to 2.0 mL of bacteriostatic water into a sterile syringe and inject slowly down the inner vial wall to minimise foaming. Gently swirl until fully dissolved. Label with the reconstitution date and store at 2 to 8 degrees C protected from light. Use within 14 to 21 days. Do not freeze reconstituted solution.

Selank Nasal Spray for Research

Selank nasal spray is the preferred delivery format for neuroactive peptide research due to rapid entry into the central nervous system via the olfactory epithelium. According to clinical research data, intranasal administration allows selank to bypass the blood-brain barrier and achieve CNS concentrations more efficiently than systemic routes.citeweb_search:24#4 For laboratory research, selank nasal spray australia formulations typically contain 200 to 300 micrograms per spray in sterile saline. Pure Peptide Factory supplies selank as a lyophilised powder for researchers who want to prepare their own nasal formulations or who prefer the flexibility of reconstitution for different research protocols. The lyophilised format ensures maximum stability and precise concentration control.

Selank Side Effects in Research Literature

According to ChemicalBook, common side effects of selank in research contexts include anxiety, headache, nausea, dizziness, and fatigue.citeweb_search:24#2 However, InnerBody notes that preclinical and clinical studies describe selank as having no significant side effects, no sedation, no myorelaxation, no amnesia, no withdrawal, and no dependence.citeweb_search:24#12 The FDA has warned that compounded selank products pose a risk for immunogenicity, particularly with certain routes of administration.citeweb_search:24#12 Potential side effects reported by clinicians include headaches, pain or redness at injection sites, sinus irritation following nasal administration, sore throat, and nausea.citeweb_search:24#4 These safety profiles are documented for research reference only and do not constitute medical guidance.

How Selank Compares to Other Research Compounds

Selank vs Semax

Semax is a synthetic heptapeptide developed in Russia for cognitive enhancement and neuroprotection. According to comparative research data, semax is primarily studied for focus, attention, and memory, while selank is primarily studied for anxiety reduction and stress resilience.citeweb_search:24#6 Semax interacts with monoaminergic and neurotrophic systems; selank modulates GABAergic and enkephalin systems. A functional connectomic study published in Doklady Biological Sciences found that selank and semax produced both general and specific effects on functional connectivity between the amygdala and temporal cortex in healthy participants.citeweb_search:24#7 For anxiety-focused research, selank is the preferred tool. For cognition and focus research, semax is more appropriate.

Selank vs DSIP

DSIP is a nonapeptide studied for sleep induction and slow-wave sleep promotion through neurotransmitter modulation. Selank is a heptapeptide studied for anxiolytic effects and stress adaptation through GABAergic and dopaminergic modulation. DSIP addresses sleep architecture; selank addresses anxiety and emotional regulation. For sleep mechanism research, DSIP is the targeted tool. For anxiety and stress research, selank is more appropriate.

Selank vs BPC-157

BPC-157 is a synthetic gastric pentapeptide primarily researched for tissue regeneration, angiogenesis, and gut healing. Selank is a tuftsin-derived peptide studied for anxiolytic, nootropic, and immunomodulatory effects. BPC-157 addresses structural repair; selank addresses neurological and emotional function. They are entirely different research compounds with no mechanistic overlap.

Selank vs 5 Amino 1mq

5 amino 1mq is a small molecule NNMT inhibitor studied for metabolic regulation through NAD+ and SIRT1 pathways. Selank is a peptide-based GABAergic modulator studied for anxiety and stress adaptation. 5 amino 1mq addresses cellular energy balance; selank addresses neurotransmitter modulation. They are not interchangeable research compounds.

Selank vs AOD-9604

AOD-9604 is a modified HGH fragment studied for direct lipolysis via beta-3 adrenergic receptor pathways. Selank is a neuropeptide with no lipolytic mechanism. AOD-9604 is positioned for fat metabolism research; selank is positioned for anxiety and neuropsychiatric research. They are entirely different research compounds.

Selank vs MOTS-c

MOTS-c is a mitochondrial-derived peptide that activates AMPK and regulates cellular energy homeostasis. Selank is a tuftsin-derived peptide that modulates GABAergic and monoaminergic neurotransmission. MOTS-c is studied for metabolic adaptation; selank is studied for anxiety and cognitive function. These are entirely different research categories.

Selank vs Hgh Fragment 176 191

Hgh fragment 176 191 is a peptide fragment targeting the lipolytic domain of human growth hormone, studied for fat metabolism. Selank is a tuftsin-derived peptide with no structural relationship to growth hormone. Hgh fragment 176 191 is investigated for subcutaneous fat reduction; selank is investigated for anxiety modulation and stress resilience. They are entirely different research tools.

Product Specifications

Purity and Analysis

• Content: 10mg lyophilised powder
• Sequence: Thr-Lys-Pro-Arg-Pro-Gly-Pro
• Molecular Formula: C33H57N11O9
• Molecular Weight: 751.9 g/mol
• Purity: Greater than or equal to 98% by HPLC
• Appearance: White to off-white lyophilised powder
• Source: Synthetic, manufactured via solid-phase peptide synthesis

Each batch is independently tested. Request the Certificate of Analysis (COA) for your specific batch number to verify purity, mass spec, and chromatography data.

Storage and Handling

• Lyophilised storage: -20 degrees C, protected from light and moisture
• Shelf life (unreconstituted): 24 months when stored correctly
• Handling: Use sterile technique. Avoid repeated freeze-thaw cycles

Shipping and Returns

We ship selank australia from our Australian facility via express domestic courier. Orders placed before 2:00 PM AEST dispatch the same business day. All peptide orders are packaged in insulated, discreet packaging with cold-chain protection where required.

• Minimum order: $200 AUD
• Free shipping: Orders over $200 AUD
• Flat rate: $15 AUD for orders under $200
• Delivery time: 1 to 5 business days Australia-wide
• Returns: Unopened vials may be returned within 30 days of delivery for store credit or replacement. We do not accept returns on reconstituted or opened products due to stability concerns. Read the full returns policy.

Frequently Asked Questions

Selank australia what is it
Selank australia refers to research-grade selank peptide supplied by Pure Peptide Factory for laboratory applications. It is a synthetic heptapeptide analogue of tuftsin studied for anxiolytic, nootropic, and immunomodulatory effects.

Selank peptide for research
Pure Peptide Factory supplies selank peptide as a 10mg lyophilised vial for laboratory research. Each batch is HPLC verified and ships with a Certificate of Analysis. Minimum order $200 AUD.

Selank 10mg dosage for research
Preclinical models typically use 0.3 to 1.0 mg per kg. Clinical studies have used 0.15 to 0.3 mg intranasally per day. In vitro work commonly uses 10 to 100 micromolar. All dosing is for laboratory research only.

Selank nasal spray australia
Pure Peptide Factory supplies selank as lyophilised powder for researchers who want to prepare nasal formulations. The powder format ensures maximum stability and precise concentration control for custom spray preparation.

Selank vs semax which is better
Neither is universally better. Selank is preferred for anxiety and stress research. Semax is preferred for focus and cognition research. The choice depends on your research question.

Selank peptide australia availability
Selank is not TGA-approved in Australia. Pure Peptide Factory supplies it as a research reference material for laboratory use only.

Is selank approved for human use
No. Selank is strictly for research and laboratory use. It is not approved by the TGA for human consumption, therapeutic application, or clinical use.

Do you ship outside Australia
Currently, we only ship to Australian addresses. We do not export peptides due to varying international customs regulations.

How do I verify the purity of my batch
Every batch ships with a unique batch number. Enter this number on our COA lookup page to download the HPLC and mass spec report for your specific vial.